Philips extends RESP offer deadline
This article was originally published in Clinica
Philips has moved the expiration date of its offer for Respironics shares to March 6. The original deadline for the offer had been February 4, but this was extended to February 22. On expiration of the second deadline, the Dutch electronics group said it had acquired 63.7 million - or 82% - of outstanding Respironics shares. In December 2007, Philips agreed to buy the Murrysville, Pennsylvania-based home healthcare and respiratory device specialist for $66 per share (see Clinica No 1288, p 1).
You may also be interested in...
At the end of the Brexit transition period, the UK will be charting its own course through the often choppy seas of medicines regulation. While it plans to retain the existing EU rules that have been transposed into domestic legislation, it also wants the freedom to tailor its regulations in areas like clinical trials, advanced therapies and product labeling.
Health technology assessment body NICE is consulting on draft guidance that recommends Axonics' device for overactive bladder.